Background
Background Despite concern about Despite concern about the incidence of coronary heart disease the incidence of coronary heart disease (CHD) inpeoplewithseverementalillness (CHD) inpeoplewithseverementalillness (SMI), there is little systematic research on (SMI), there is little systematic research on CHD risk factors in this population. CHD risk factors in this population.
Aims Aims To compare the main risk factors
To compare the main risk factors for CHD in people with and without SMI for CHD in people with and without SMI in primary care, to investigate the role of in primary care, to investigate the role of socio-economic variables, and to examine socio-economic variables, and to examine any association between antipsychotic any association between antipsychotic medication and CHD risk. medication and CHD risk.
Method
Method Cross-sectional screening.
Cross-sectional screening.
Results
Results In total, 75 of182 general In total, 75 of182 general prac practice patients with SMI and150 of 313 tice patients with SMI and150 of 313 such patients without SMI attended the such patients without SMI attended the interview. SMI was associated with: raised interview. SMI was associated with: raised 10 -year CHD risk scores (OR 10 -year CHD risk scores (OR¼1.8,95% CI 1.8,95% CI 1.0^3.1); high-density-lipoprotein (HDL)-1.0^3.1); high-density-lipoprotein (HDL)cholesterollevels cholesterollevels 5 51.0 mmol/l (OR 1.0 mmol/l (OR¼4.0, 4.0, 95% CI1.5^10.7); raised cholesterol/HDL-95% CI1.5^10.7); raised cholesterol/HDLcholesterol ratios (OR cholesterol ratios (OR¼1.8,95% CI 1.8,95% CI 1.0^3.2); diabetes mellitus (OR 1.0^3.2); diabetes mellitus (OR¼3.8,95% 3.8,95% CI1.1^13.3) and smoking (OR CI1.1^13.3) and smoking (OR¼3.0,95% CI 3.0,95% CI 1.7^3.4).These associations varied signifi-1.7^3.4).These associations varied significantly with age. Adjustment for unemploy-cantly with age. Adjustment for unemployment did not fully explain the associations. ment did not fully explain the associations.
Conclusions Conclusions Excess risk factors for
Excess risk factors for CHD are not wholly accounted for by CHD are not wholly accounted for by medication or socio-economic depriva-medication or socio-economic deprivation. tion.There is an urgent need for CHD There is an urgent need for CHD screening and for relevant interventions screening and for relevant interventions for smoking cessation and diabetes, as well for smoking cessation and diabetes, as well as advice on diet and exercise, in patients as advice on diet and exercise, in patients with SMI. with SMI.
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People with severe mental illness (SMI) People with severe mental illness (SMI) experience an excess of coronary heart experience an excess of coronary heart disease (CHD) morbidity and mortality disease (CHD) morbidity and mortality ; Phelan Phelan et al et al, 2001) . , 2001). Mortality rates for cardiovascular disease Mortality rates for cardiovascular disease in this group are increasing, and it is in this group are increasing, and it is CHD, not suicide, that is the biggest killer CHD, not suicide, that is the biggest killer (Hansen (Hansen et al et al, 2001; Lawrence , 2001; Lawrence et al et al, , 2003) . This may be exacerbated by the 2003). This may be exacerbated by the metabolic and endocrine effects of anti-metabolic and endocrine effects of antipsychotics, including weight gain psychotics, including weight gain and impaired glucose and impaired glucose homoeostasis (Haddad, 2004) . There has homoeostasis (Haddad, 2004) . There has been little systematic comparative research been little systematic comparative research regarding CHD risk factors and involving regarding CHD risk factors and involving representative samples. The National representative samples. The National Institute for Clinical Excellence (2002) Institute for Clinical Excellence (2002) guidelines on schizophrenia emphasise guidelines on schizophrenia emphasise cardiovascular ill health, but identify little cardiovascular ill health, but identify little good-quality research, deeming this field a good-quality research, deeming this field a major priority. Specifically, the current major priority. Specifically, the current absence of evidence regarding lipid profiles absence of evidence regarding lipid profiles is notable in guidelines from both Europe is notable in guidelines from both Europe and the USA (Drug and Therapeutics and the USA (Drug and Therapeutics Bulletin, 2004; Marder Bulletin, 2004; Marder et al et al, 2004) . , 2004) . We aimed to compare the prevalence We aimed to compare the prevalence of the four most important risk factors for of the four most important risk factors for CHD (Khot CHD (Khot et al et al, 2003) in people with , 2003) in people with and without SMI in primary care, and to and without SMI in primary care, and to compare the overall Framingham CHD risk compare the overall Framingham CHD risk scores (Hingorani & Vallance, 1999) . One scores (Hingorani & Vallance, 1999) . One of our secondary aims was to investigate of our secondary aims was to investigate the role of socio-economic variables in the role of socio-economic variables in any relationship between CHD risk and any relationship between CHD risk and schizophrenia. Such factors have often been schizophrenia. Such factors have often been ignored, despite the fact that schizophrenia ignored, despite the fact that schizophrenia is strongly associated with adverse socio-is strongly associated with adverse socioeconomic circumstances (Agerbo economic circumstances (Agerbo et al et al, , 2004) , as are CHD mortality and CHD risk 2004) , as are CHD mortality and CHD risk factors (Brunner factors (Brunner et al et al, 1999) . Our other , 1999) . Our other secondary aim was to investigate any asso-secondary aim was to investigate any association between antipsychotic medication ciation between antipsychotic medication and CHD risk. and CHD risk.
METHOD METHOD
We invited patients from seven general We invited patients from seven general practices in North London to attend for practices in North London to attend for CHD risk factor screening at their practice CHD risk factor screening at their practice (Osborn (Osborn et al et al, 2003) . Invitations were sent , 2003). Invitations were sent by letter, followed by up to three telephone by letter, followed by up to three telephone calls. We invited all patients with a calls. We invited all patients with a practice-computer diagnosis of schizo-practice-computer diagnosis of schizophrenia, schizoaffective disorder or other phrenia, schizoaffective disorder or other non-affective chronic psychotic illness of non-affective chronic psychotic illness of more than 1 year's duration. We also more than 1 year's duration. We also invited a comparison group (approximately invited a comparison group (approximately twice the size of the SMI group), without a twice the size of the SMI group), without a psychotic illness, and chosen at random by psychotic illness, and chosen at random by the general-practice computer. To calculate the general-practice computer. To calculate the Framingham risk score we only invited the Framingham risk score we only invited people aged between 30 and 75 years people aged between 30 and 75 years who, according to their general practice who, according to their general practice record, had no pre-existing CHD. We esti-record, had no pre-existing CHD. We estimated that we would need to recruit 75 mated that we would need to recruit 75 patients with and 150 patients without patients with and 150 patients without SMI to enable us to demonstrate previously SMI to enable us to demonstrate previously reported differences in individual CHD risk reported differences in individual CHD risk factors at 90% power and a 5% level of factors at 90% power and a 5% level of significance. This was based on published significance. This was based on published conservative differences in smoking preva-conservative differences in smoking prevalence (Kendrick, 1996) and unpublished lence (Kendrick, 1996) and unpublished data on total cholesterol levels from a small data on total cholesterol levels from a small study of dietary factors and schizophrenia study of dietary factors and schizophrenia (McCreadie (McCreadie et al et al, 1998; R. McCreadie, , 1998; R. McCreadie, personal communication, 2000) . In this personal communication, 2000) . In this study, the mean total cholesterol level in study, the mean total cholesterol level in males with schizophrenia was 5.4 mmol/l males with schizophrenia was 5.4 mmol/l (s.d. (s.d.¼0.9), compared with 5.0 mmol 0.9), compared with 5.0 mmol (s.d. (s.d.¼0.8) in controls matched for age and 0.8) in controls matched for age and employment status. employment status.
We collected data on age, gender, self-We collected data on age, gender, selfreported smoking status, prescribed medi-reported smoking status, prescribed medication and a number of socio-economic cation and a number of socio-economic and demographic variables at interview. and demographic variables at interview. Recall of general practice diagnosis of Recall of general practice diagnosis of ischaemic heart disease or diabetes mellitus ischaemic heart disease or diabetes mellitus was noted, as was the most recent body was noted, as was the most recent body mass index measurement. The first two mass index measurement. The first two questions of the Rose Angina Question-questions of the Rose Angina Questionnaire were used to screen further for un-naire were used to screen further for undiagnosed ischaemic heart disease (Cook diagnosed ischaemic heart disease (Cook et al et al, 1989) . Blood pressure was measured , 1989). Blood pressure was measured at the beginning and end of the interview at the beginning and end of the interview using an automated sphygmomanometer using an automated sphygmomanometer (Whincup (Whincup et al et al, 1992) , and the mean value , 1992), and the mean value was determined. A non-fasting blood sam-was determined. A non-fasting blood sample was taken for measurement of total ple was taken for measurement of total cholesterol, high-density-lipoprotein (HDL)-cholesterol, high-density-lipoprotein (HDL)cholesterol and random glucose levels. cholesterol and random glucose levels. The Framingham risk score was calculated The Framingham risk score was calculated using commercial software (Hingorani & using commercial software (Hingorani & Vallance, 1999) . This risk score is an algo-Vallance, 1999). This risk score is an algorithm of age, gender, HDL-cholesterol le-rithm of age, gender, HDL-cholesterol level, total cholesterol level, blood pressure, vel, total cholesterol level, blood pressure, smoking and diabetic status. The scores smoking and diabetic status. The scores are well established and are more powerful are well established and are more powerful predictors of future CHD than individual predictors of future CHD than individual risk factors. The absolute CHD risk score risk factors. The absolute CHD risk score may underestimate 'excess CHD risk' at may underestimate 'excess CHD risk' at younger ages, but the CHD risk score soft-younger ages, but the CHD risk score software also calculates the expected risk score ware also calculates the expected risk score for a person's age and gender. The differ-for a person's age and gender. The difference between these two results provides a ence between these two results provides a measure of a person's excess CHD risk. measure of a person's excess CHD risk.
The most recent diagnosis for patients The most recent diagnosis for patients with SMI was always confirmed by a letter with SMI was always confirmed by a letter from a consultant psychiatrist that was held from a consultant psychiatrist that was held in the general practice notes. The dose of in the general practice notes. The dose of medication in chlorpromazine equivalents medication in chlorpromazine equivalents was calculated . If a patient was calculated . If a patient was taking more than one antipsychotic, was taking more than one antipsychotic, the chlorpromazine equivalents were the chlorpromazine equivalents were summed. Dose as a percentage of the maxi-summed. Dose as a percentage of the maximum mum British National Formulary British National Formulary dose was dose was also calculated. As there is considerable also calculated. As there is considerable interest in associations between CHD and interest in associations between CHD and olanzapine (Koro olanzapine (Koro et al et al, 2002) and clozapine , 2002) and clozapine (Lund (Lund et al et al, 2001) , we compared the CHD , 2001), we compared the CHD risk in patients who were taking either of risk in patients who were taking either of these medications with the risk in those these medications with the risk in those who were not. All of the participants gave who were not. All of the participants gave their written informed consent, and ethical their written informed consent, and ethical approval was obtained from the Royal approval was obtained from the Royal Free Hospital and the Camden and Free Hospital and the Camden and Islington Community NHS Trust local Islington Community NHS Trust local research ethics committees. research ethics committees.
Statistical analysis Statistical analysis
Initial univariate associations between SMI Initial univariate associations between SMI and a variety of outcomes guided which co-and a variety of outcomes guided which covariates should be included in subsequent variates should be included in subsequent multivariate analysis. If continuous vari-multivariate analysis. If continuous variables were normally distributed, any asso-ables were normally distributed, any association with SMI was explored by linear ciation with SMI was explored by linear multiple regression. Outcome variables, multiple regression. Outcome variables, such as CHD risk score and cholesterol such as CHD risk score and cholesterol level, were also dichotomised around clini-level, were also dichotomised around clinically or statistically significant values, cally or statistically significant values, allowing analysis of associations by multi-allowing analysis of associations by multiple logistic regression. Age and gender were ple logistic regression. Age and gender were included included a priori a priori. Unemployment was . Unemployment was included because on univariate analyses it included because on univariate analyses it was the variable most consistently and was the variable most consistently and robustly associated with both CHD risk robustly associated with both CHD risk scores and individual risk factors for scores and individual risk factors for CHD. We tested the contribution of vari-CHD. We tested the contribution of variables and interaction terms by comparing ables and interaction terms by comparing models that included and excluded the models that included and excluded the component of interest, using likelihood component of interest, using likelihood ratio tests. Any influence of the sampling ratio tests. Any influence of the sampling strategy by practice was first assessed by strategy by practice was first assessed by adding practice as a covariate to final adding practice as a covariate to final models. We then reassessed the statistical models. We then reassessed the statistical models using survey techniques in Stata models using survey techniques in Stata version 6 for Windows and examining for version 6 for Windows and examining for any design effect using the 'design effect' any design effect using the 'design effect' (DEFT) scores for each model. The DEFT (DEFT) scores for each model. The DEFT score quantifies the influence of the cluster score quantifies the influence of the cluster design, as a ratio of the cluster result to a design, as a ratio of the cluster result to a simple random-sampling-design result. simple random-sampling-design result.
RESULTS

Response rates and numbers Response rates and numbers
Uptake rates for the CHD screening have Uptake rates for the CHD screening have been reported previously (Osborn been reported previously (Osborn et al et al, , 2003 ). There were no major clinical or 2003). There were no major clinical or demographic predictors of participation demographic predictors of participation that might have suggested that the sample that might have suggested that the sample was unrepresentative. A total of 666 was unrepresentative. A total of 666 patients were originally identified for invi-patients were originally identified for invitation for screening, of whom 495 people tation for screening, of whom 495 people were found to be eligible and were included were found to be eligible and were included in the denominator. In total, 75 patients in the denominator. In total, 75 patients with SMI and 150 without SMI attended with SMI and 150 without SMI attended the interview, of whom 3 individuals were the interview, of whom 3 individuals were excluded because possible pre-existing excluded because possible pre-existing CHD was detected. Valid data were there-CHD was detected. Valid data were therefore available for 74 out of 182 eligible fore available for 74 out of 182 eligible patients with SMI and for 148 out of 313 patients with SMI and for 148 out of 313 patients without SMI. Exclusion rates for patients without SMI. Exclusion rates for CHD, either before or during interview, CHD, either before or during interview, were similar in the two groups. Of the were similar in the two groups. Of the 666 potential participants, 3 out of 228 666 potential participants, 3 out of 228 patients (1.3%) in the SMI group had patients (1.3%) in the SMI group had CHD recorded in their general practice CHD recorded in their general practice notes or at interview, compared with notes or at interview, compared with 10 out of 438 patients (2.3%) in the 10 out of 438 patients (2.3%) in the comparison group. comparison group.
2 7 2 2 7 2 
Characteristics of participants Characteristics of participants
The demographic and socio-economic pro-The demographic and socio-economic profiles of the two groups are shown in Table  files of the two groups are shown in Table  1 . The SMI group was characterised by 1. The SMI group was characterised by low levels of income, home ownership, low levels of income, home ownership, car ownership and employment. In total, car ownership and employment. In total, 66 out of 74 participants (89%) in the 66 out of 74 participants (89%) in the SMI group had a diagnosis of schizo-SMI group had a diagnosis of schizophrenia, 6 had a diagnosis of schizoaffec-phrenia, 6 had a diagnosis of schizoaffective disorder, and the remaining 2 had a tive disorder, and the remaining 2 had a diagnosis of a chronic or persistent delu-diagnosis of a chronic or persistent delusional disorder. Diagnoses had been made sional disorder. Diagnoses had been made between 2 and 43 years previously (mean between 2 and 43 years previously (mean 14.6 years, s.d. 14.6 years, s.d.¼10.5). The number of in-10.5). The number of inpatient psychiatric admissions in the past patient psychiatric admissions in the past 5 years ranged from 0 to 8 (mean 0.93, 5 years ranged from 0 to 8 (mean 0.93, s.d. s.d.¼1.34). Only 9 patients (12%) lived in 1.34). Only 9 patients (12%) lived in sheltered or hostel-type accommodation. sheltered or hostel-type accommodation. In total, 67 out of 74 patients (91%) had In total, 67 out of 74 patients (91%) had been seen in psychiatric secondary care been seen in psychiatric secondary care within the past 2 years, 56 (76%) within within the past 2 years, 56 (76%) within the past 9 months, but only 37 (50%) the past 9 months, but only 37 (50%) within the past 3 months. Therefore many within the past 3 months. Therefore many of these patients did not require the most of these patients did not require the most intensive community care. intensive community care.
Psychiatric medication Psychiatric medication
In total, 20 out of 74 patients (27%) in the In total, 20 out of 74 patients (27%) in the SMI sample were taking long-acting intra-SMI sample were taking long-acting intramuscular depot antipsychotics, and 35 muscular depot antipsychotics, and 35 patients (47%) were taking atypical anti-patients (47%) were taking atypical antipsychotics. Risperidone was not available psychotics. Risperidone was not available as a depot preparation as data collection as a depot preparation as data collection took place between 1999 and 2002. The took place between 1999 and 2002. The dose of medication in chlorpromazine dose of medication in chlorpromazine equivalents could be calculated for 49 equivalents could be calculated for 49 patients. The missing data are explained patients. The missing data are explained by the fact that some patients were by the fact that some patients were prescribed atypical antipsychotics such prescribed atypical antipsychotics such as olanzapine, without chlorpromazine as olanzapine, without chlorpromazine equivalents . The median equivalents CHD risk score results CHD risk score results
Univariate results Univariate results
Patients with SMI had significantly lower Patients with SMI had significantly lower HDL-cholesterol levels, and a higher total HDL-cholesterol levels, and a higher total cholesterol/HDL-cholesterol ratio, but cholesterol/HDL-cholesterol ratio, but showed little overall difference in blood showed little overall difference in blood pressure ( Table 2 ). They were also signifi-pressure (Table 2 ). They were also significantly more likely to smoke, to have a cantly more likely to smoke, to have a diagnosis of diabetes and to have a raised diagnosis of diabetes and to have a raised overall CHD risk score for their age and overall CHD risk score for their age and gender (Table 3) . Patients with SMI were gender (Table 3) . Patients with SMI were twice as likely to have a raised Framingham twice as likely to have a raised Framingham risk score for their age and gender risk score for their age and gender compared with patients without SMI compared with patients without SMI (Table 3) . Participants with SMI had higher (Table 3) . Participants with SMI had higher absolute 10-year CHD risk scores (median absolute 10-year CHD risk scores (median 10-year risk 10-year risk¼5%; IQR 2-12) than partici-5%; IQR 2-12) than participants without SMI (median 10-year pants without SMI (median 10-year risk risk¼4%; IQR 2-9%) (Mann-Whitney 4%; IQR 2-9%) (Mann-Whitney U U-test, -test, z z¼2.0; 2.0; P P¼0.049). 0.049).
Multivariate analysis Multivariate analysis
Effect of increasing age Effect of increasing age. The magnitude of . The magnitude of the difference in the results between the difference in the results between 2 7 3 2 7 3 participants with and without SMI varied participants with and without SMI varied significantly with age. More patients with significantly with age. More patients with SMI than controls exhibited raised 10-year SMI than controls exhibited raised 10-year CHD risk scores, except above the age of CHD risk scores, except above the age of 60 years (Fig. 1) . A logistic regression 60 years (Fig. 1) . A logistic regression model including an age-SMI interaction model including an age-SMI interaction term, adjusted for age, unemployment and term, adjusted for age, unemployment and gender, predicted having a raised CHD risk gender, predicted having a raised CHD risk score better than a model that did not score better than a model that did not include the interaction term (Table 3) . This include the interaction term (Table 3) . This is because the odds ratios between SMI and is because the odds ratios between SMI and excess CHD risk differ significantly accord-excess CHD risk differ significantly according to age group. The source of this ing to age group. The source of this interaction with age was explored further interaction with age was explored further by examining logistic models between by examining logistic models between SMI and each individual component of SMI and each individual component of the CHD risk score. The most likely sources the CHD risk score. The most likely sources of the interaction were smoking, total of the interaction were smoking, total cholesterol concentration and hypertension cholesterol concentration and hypertension ( . These individual factors are also shown according to age factors are also shown according to age group in Fig. 2. Both Fig. 1 and Fig. 2 group in Fig. 2. Both Fig. 1 and Fig. 2 suggest that the results for patients over suggest that the results for patients over 60 years of age contradict the results for 60 years of age contradict the results for the younger participants. For this reason, the younger participants. For this reason, the main results were also explored in a re-the main results were also explored in a restricted sample from which the oldest age stricted sample from which the oldest age group (over 60 years) had been excluded. group (over 60 years) had been excluded.
Multiple regression analysis confirmed that Multiple regression analysis confirmed that patients with SMI in this age group showed patients with SMI in this age group showed greater differences in CHD risk score (the greater differences in CHD risk score (the difference between personal CHD risk and difference between personal CHD risk and expected CHD risk for the patient's age expected CHD risk for the patient's age 2 74 2 74 Fig. 1 Scatter plot of differences in 10-year coronary heart disease (CHD) risk score according to age. SMI, Scatter plot of differences in 10-year coronary heart disease (CHD) risk score according to age. SMI, severe mental illness. Example of excess CHD risk calculation: if an individual's 10-year CHD risk score is 5%, severe mental illness. Example of excess CHD risk calculation: if an individual's 10-year CHD risk score is 5%, and the expected value for someone of the same age and gender is 2%, their excess risk is calculated as and the expected value for someone of the same age and gender is 2%, their excess risk is calculated as (5% (5%7 72%) 2%)¼3%. 3%. and gender) after adjustment for age, gen-and gender) after adjustment for age, gender and unemployment ( 
Effect of unemployment
Effect of unemployment. With regard to . With regard to continuous outcomes, the results were most continuous outcomes, the results were most pronounced in the under-60s (Table 2 , pronounced in the under-60s (Table 2, compare columns 5 and 6). Presence of compare columns 5 and 6). Presence of SMI still predicted a greater magnitude of SMI still predicted a greater magnitude of excess CHD risk after adjustment for age, excess CHD risk after adjustment for age, gender and unemployment. It also gender and unemployment. It also predicted higher total cholesterol/HDL-predicted higher total cholesterol/HDLcholesterol ratios and lower HDL-cholesterol ratios and lower HDLcholesterol levels in this age group. For cholesterol levels in this age group. For binary outcomes, unemployment partially binary outcomes, unemployment partially explained the associations of SMI with a explained the associations of SMI with a raised CHD risk score, smoking status raised CHD risk score, smoking status and low HDL-cholesterol levels and low HDL-cholesterol levels (Table 3) .
( Table 3 ). The inclusion of other socio-The inclusion of other socio-economic economic variables (listed in Table 1) in the multi-variables (listed in Table 1) in the multivariate models had little further effect on variate models had little further effect on the main associations, and those data are the main associations, and those data are not presented here. not presented here.
Effect of medication Effect of medication. Among patients with
. Among patients with SMI, few medication variables were SMI, few medication variables were associated with excess CHD risk or associated with excess CHD risk or with individual CHD risk factors (Table  with individual CHD risk factors (Table  4 ). The exception was higher doses of 4). The exception was higher doses of medication, which were associated with medication, which were associated with increased CHD risk scores (most likely increased CHD risk scores (most likely to be caused by increased smoking). In to be caused by increased smoking). In total, 10 out of 17 patients (59%) on olan-total, 10 out of 17 patients (59%) on olanzapine or clozapine showed a raised CHD zapine or clozapine showed a raised CHD risk score, compared with 27 out of 55 risk score, compared with 27 out of 55 patients who were not on such patients who were not on such medications (49%; medications (49%; w w 2 2 ¼0.5, 0.5, P P¼0.48). The 0.48). The proportion of individuals who were proportion of individuals who were diagnosed with diabetes was also diagnosed with diabetes was also higher among patients on these medica-higher among patients on these medications, but again the trend was non-tions, but again the trend was nonsignificant significant (3/18 (17%) (3/18 (17%) v v. 4/56 (7%); . 4/56 (7%); w w 2 2 ¼1.4, 1.4, P P¼0.23). 0.23).
Design effect
Design effect. Adding practice as a co-. Adding practice as a covariate to the final models had little effect variate to the final models had little effect on any of the main results. The DEFT on any of the main results. The DEFT scores were close to 1 and were all less than scores were close to 1 and were all less than 2, which also suggests that there was very 2, which also suggests that there was very little variation in effect between practices. little variation in effect between practices.
DISCUSSION DISCUSSION
Participants with SMI were almost twice as Participants with SMI were almost twice as likely to have a raised 10-year CHD risk likely to have a raised 10-year CHD risk score as patients in the general practice score as patients in the general practice comparison group. This result was robust comparison group. This result was robust whether scores were analysed continuously whether scores were analysed continuously or categorically, and after taking into or categorically, and after taking into account age and gender, and was far more account age and gender, and was far more pronounced as age approached 60 years. pronounced as age approached 60 years. This magnitude of risk is comparable with This magnitude of risk is comparable with the twofold excess of CHD deaths reported the twofold excess of CHD deaths reported 2 7 5 2 7 5 ( , 2003) . The main excess risk factors were increased smoking, lower factors were increased smoking, lower HDL-cholesterol levels, higher total HDL-cholesterol levels, higher total cholesterol/HDL-cholesterol ratios, in-cholesterol/HDL-cholesterol ratios, increased likelihood of a diagnosis of dia-creased likelihood of a diagnosis of diabetes, and a weak propensity for raised betes, and a weak propensity for raised blood pressure with advancing age. These blood pressure with advancing age. These factors are those of the metabolic syn-factors are those of the metabolic syndrome. The pro-atherogenic lipid results drome. The pro-atherogenic lipid results are novel, and are particularly important are novel, and are particularly important given the paucity of previous epidemio-given the paucity of previous epidemiological evidence. Dyslipidaemia and logical evidence. Dyslipidaemia and diabetes were more common regardless of diabetes were more common regardless of antipsychotic medication, and despite the antipsychotic medication, and despite the fact that body mass indices were similar in fact that body mass indices were similar in the two groups. Similarities in body mass the two groups. Similarities in body mass index may seem surprising, but previous index may seem surprising, but previous community comparisons have not consis-community comparisons have not consistently shown that more people with SMI tently shown that more people with SMI have a body mass index above 25 kg/m have a body mass index above 25 kg/m 2 2 (e.g. Kendrick, 1996; Brown (e.g. Kendrick, 1996; Brown et al et al, 1999) . , 1999). The results of body mass index compari-The results of body mass index comparisons will vary according to which sub-sons will vary according to which subgroups with SMI participate in studies, groups with SMI participate in studies, and will also be influenced by the high rates and will also be influenced by the high rates of obesity in the general population. of obesity in the general population.
The CHD risk of the oldest participants The CHD risk of the oldest participants with SMI ( with SMI (4 460 years) was less marked, 60 years) was less marked, with less smoking, dyslipidaemia and with less smoking, dyslipidaemia and hypertension, possibly reflecting a healthy-hypertension, possibly reflecting a healthysurvivor effect whereby the people with survivor effect whereby the people with SMI who had the highest CHD risk factors SMI who had the highest CHD risk factors had already died. It is not surprising that had already died. It is not surprising that excess CHD risk factors are increasingly excess CHD risk factors are increasingly detected with advancing age, as they detected with advancing age, as they become more prevalent with age. Although become more prevalent with age. Although people with SMI remain at increased risk people with SMI remain at increased risk of developing CHD even after their socio-of developing CHD even after their socioeconomic circumstances have been taken economic circumstances have been taken into account, such adversity does explain into account, such adversity does explain some of the association. some of the association.
Strengths and weaknesses Strengths and weaknesses of the study of the study
The strengths of this study include the The strengths of this study include the source of the participants and the recruit-source of the participants and the recruitment of a relevant comparison group from ment of a relevant comparison group from the same source as the patients with SMI. the same source as the patients with SMI. The primary-care setting allowed recruit-The primary-care setting allowed recruitment of all patients with SMI, not just those ment of all patients with SMI, not just those in secondary care. Previous cardiovascular in secondary care. Previous cardiovascular outcome research has often focused on outcome research has often focused on institutionalised samples, or at least on institutionalised samples, or at least on patients with the most chronic and patients with the most chronic and disabling forms of the illness (e.g. disabling forms of the illness (e.g. McCreadie, McCreadie, 2003) . Our study shows that 2003). Our study shows that excess CHD risk is not restricted to the excess CHD risk is not restricted to the sub-groups with SMI. The reporting of the sub-groups with SMI. The reporting of the 'big four' CHD risk factors (Khot 'big four' CHD risk factors (Khot et al et al, , 2003) of the Framingham risk score, rather 2003) of the Framingham risk score, rather than one or two risk factors, is novel. The than one or two risk factors, is novel. The contribution of socio-economic circum-contribution of socio-economic circumstances to inequalities in cardiovascular stances to inequalities in cardiovascular health for people with SMI has previously health for people with SMI has previously been neglected. been neglected.
The limitations of our study include its The limitations of our study include its cross-sectional nature and the omission of cross-sectional nature and the omission of any electrocardiogram measure for possible any electrocardiogram measure for possible left ventricular hypertrophy. The latter was left ventricular hypertrophy. The latter was not included because of the weaker contri-not included because of the weaker contribution of left ventricular hypertrophy to bution of left ventricular hypertrophy to population CHD risk (Shaper population CHD risk (Shaper et al et al, 1987; , 1987; Khot Khot et al et al, 2003) , and because extensive , 2003), and because extensive electrocardiological studies in patients with electrocardiological studies in patients with SMI have not revealed an excess of left ven-SMI have not revealed an excess of left ventricular hypertrophy. Although diabetes tricular hypertrophy. Although diabetes was coded on the basis of general practi-was coded on the basis of general practitioner diagnosis, random blood glucose tioner diagnosis, random blood glucose screening contributed to our main outcome. screening contributed to our main outcome. The increasing risk of diabetes in people The increasing risk of diabetes in people with SMI justifies more intensive screening with SMI justifies more intensive screening for the condition. for the condition.
The response rate of approximately The response rate of approximately 45% might initially seem modest, but this 45% might initially seem modest, but this is similar to rates for other community is similar to rates for other community research involving blood tests, such as the research involving blood tests, such as the Health Survey for England (47%; Erens & Health Survey for England (47%; Erens & Primatesta, 1999) . The possibility of bias Primatesta, 1999) . The possibility of bias was minimised but not eliminated by the was minimised but not eliminated by the incorporation of a comparison group. incorporation of a comparison group. Criticisms of the Framingham scores or of Criticisms of the Framingham scores or of dichotomising factors such as excess CHD dichotomising factors such as excess CHD risk, hypertension and hypercholesterol-risk, hypertension and hypercholesterolaemia apply to both groups, and measure-aemia apply to both groups, and measurement error could explain the results only ment error could explain the results only if inaccuracy preferentially favoured the if inaccuracy preferentially favoured the group with or the group without SMI. group with or the group without SMI. Selection bias has been carefully considered Selection bias has been carefully considered previously (Osborn previously (Osborn et al et al, 2003) . Although , 2003) . Although patients who frequently consulted their patients who frequently consulted their general practitioner were more likely to general practitioner were more likely to participate, again this was true for both participate, again this was true for both groups. No psychiatric, medication or so-groups. No psychiatric, medication or socio-demographic variables predicted parti-cio-demographic variables predicted participation in the study. cipation in the study.
There was a non-significant difference There was a non-significant difference in gender distribution, with more women in gender distribution, with more women in the non-SMI group (Table 1) . Although in the non-SMI group (Table 1) . Although this could potentially exaggerate the excess this could potentially exaggerate the excess CHD risk factors in patients with SMI, CHD risk factors in patients with SMI, continuous variables (Table 2) and odds continuous variables (Table 2 ) and odds ratios (Table 3) changed little after adjust-ratios (Table 3) changed little after adjusting for age and gender, especially in ing for age and gender, especially in patients under 60 years of age. patients under 60 years of age.
The study was neither powered nor The study was neither powered nor designed to examine sub-groups or effects designed to examine sub-groups or effects of atypical antipsychotics, so those results of atypical antipsychotics, so those results should be interpreted with caution. should be interpreted with caution.
Importance Importance
Socio-economic determinants of health are Socio-economic determinants of health are now one of the main priority of the World now one of the main priority of the World Health Organization (2004) , and there is Health Organization (2004) , and there is no better example of how such determi-no better example of how such determinants affect health than patients with nants affect health than patients with SMI. However, we have demonstrated that SMI. However, we have demonstrated that SMI itself can incur CHD risk, over and SMI itself can incur CHD risk, over and above that associated with the socio-above that associated with the socioeconomic deprivation experienced by these economic deprivation experienced by these patients. Our results emphasise the clinical patients. Our results emphasise the clinical necessity for CHD risk factor screening necessity for CHD risk factor screening for people with SMI. The burden of for people with SMI. The burden of individual CHD risk factors may be individual CHD risk factors may be further compounded by the problems of further compounded by the problems of weight gain and weight gain and impaired glucose control linked to the use impaired glucose control linked to the use of antipsychotics (Haddad, 2004) , and the of antipsychotics (Haddad, 2004) , and the arrhythmogenic properties of conventional arrhythmogenic properties of conventional and newer antipsychotic drugs (Glassman and newer antipsychotic drugs (Glassman & Bigger, 2001) . This & Bigger, 2001) . This highlights people highlights people with SMI as candi with SMI as candidates for more intensive dates for more intensive CHD-focused interventions. This study has CHD-focused interventions. This study has identified the need to develop focused inter-identified the need to develop focused interventions for smoking cessation, screening ventions for smoking cessation, screening for diabetes and advice on diet, exercise for diabetes and advice on diet, exercise and other methods of enhancing HDL-cho-and other methods of enhancing HDL-cholesterol levels and reducing the risk of CHD lesterol levels and reducing the risk of CHD in people with SMI. Questions about the in people with SMI. Questions about the best form, clinical setting and intensity of best form, clinical setting and intensity of such interventions therefore require urgent such interventions therefore require urgent attention. Since around half of the patients attention. Since around half of the patients who were invited to participate took up our who were invited to participate took up our CHD screening offer, more opportunistic CHD screening offer, more opportunistic screening may be indicated when patients screening may be indicated when patients are seen for other clinical reasons. are seen for other clinical reasons.
Brown, S., Birtwistle, J., Roe, L., Brown, S., Birtwistle, J., Roe, L., et al et al (1999) SMI is independently associated with excess CHD risk factors including smoking, raised cholesterol levels, low HDL-cholesterol levels and diabetes, even after raised cholesterol levels, low HDL-cholesterol levels and diabetes, even after controlling for the effects of antipsychotic medication and socio-economic controlling for the effects of antipsychotic medication and socio-economic deprivation. deprivation.
& & Screening for CHD risk factors is essential in this patient group.
Screening for CHD risk factors is essential in this patient group.
& & Interventions to improve cardiovascular health should focus on smoking cessation Interventions to improve cardiovascular health should focus on smoking cessation and more aggressive management of cholesterol levels and diabetes if appropriate. and more aggressive management of cholesterol levels and diabetes if appropriate.
LIMITATIONS LIMITATIONS
& & Response rates were similar to those in other community studies involving blood Response rates were similar to those in other community studies involving blood tests. Although no selection bias was detected on examination for predictors of tests. Although no selection bias was detected on examination for predictors of participation, this possibility cannot be excluded altogether. participation, this possibility cannot be excluded altogether.
& & The sample was drawn from primary-care settings, representing the full clinical
The sample was drawn from primary-care settings, representing the full clinical spectrum of SMI.Therefore the results obtained for secondary-care samples might spectrum of SMI.Therefore the results obtained for secondary-care samples might differ, potentially being exaggerated. differ, potentially being exaggerated.
& & The results for sub-groups such as different types of medication should be
The results for sub-groups such as different types of medication should be interpreted with caution, as the study was not powered to examine such interpreted with caution, as the study was not powered to examine such associations. associations.
